Fora Capital, LLC United Therapeutics Corp Transaction History

Fora Capital, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$211.82 - $248.24 $1.19 Million - $1.39 Million	5,603 New	5,603 $1.27 Million
Q4 2022 Feb 08, 2023	BUY	$205.95 - $280.43 $1.07 Million - $1.46 Million	5,219 New	5,219 $1.45 Million
Q2 2022 Aug 11, 2022	BUY	$174.81 - $241.14 $902,369 - $1.24 Million	5,162 New	5,162 $1.22 Million
Q3 2021 Nov 15, 2021	SELL	$179.86 - $214.88 $30,935 - $36,959	-172 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$170.47 - $211.93 $29,320 - $36,451	172 New	172 $31 Million
Q3 2020 Nov 13, 2020	SELL	$99.9 - $121.13 $90,109 - $109,259	-902 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$92.74 - $125.82 $615,422 - $834,941	-6,636 Reduced 88.03%	902 $109 Million
Q1 2020 May 15, 2020	BUY	$79.39 - $115.35 $246,585 - $358,277	3,106 Added 70.08%	7,538 $714,000
Q4 2019 Feb 14, 2020	BUY	$78.31 - $95.34 $347,069 - $422,546	4,432 New	4,432 $390,000

679

42.1M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.9B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Fora Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Fora Capital, LLC with notifications on news.